A late-onset sporadic case of SPG4 (1726T>C mutant) accompanied by polyneuropathy with diabetes mellitus

Mami Fukunaga, Yasumasa Ohyagi, Mitsuya Morita, Hiroshi Shigeto, Takayuki Taniwaki, Jun-Ichi Kira

Research output: Contribution to journalArticle

Abstract

We report a 73-year-old man with SPG4. From aged 53 he had diabetes mellitus and at 64 he developed spastic paraparesis and urinary disturbance. At 70 years, he began to walk with a stick and noted abnormal sensations in bilateral feet. There was no relevant family history. Moderate spasticity with mild muscle weakness, markedly brisk tendon reflex with pathological reflexes, and mildly abnormal sensation in bilateral lower extremities, and markedly spastic gait were found. MRI showed mild C4-C7 spondylosis and L4-5 disk protrusion but no abnormality of the corpus callosum. Nerve conduction and needle EMG studies revealed various abnormalities in distal (MCV, SCV) and proximal (F-wave) peripheral nerves, but no neurogenic changes in limb muscles. We found a missense spastin gene mutation (1726T>C) that causes Leu534Pro substitution. This spastin gene mutation was novel in Japanese, but has been reported in an Italian family. The present case's neuropathy might be related to diabetes mellitus, because SPG4 is generally not associated with neuropathy. However, recent studies suggest that SPG4 patients sometimes have subclinical neuropathy, and longer disease duration may contribute to peripheral neuropathy. Further study of clinical characteristics associated with the Leu534Pro mutation will be necessary.

Original languageEnglish
Pages (from-to)359-361
Number of pages3
JournalClinical Neurology
Volume47
Issue number6
Publication statusPublished - Jun 1 2007

Fingerprint

Polyneuropathies
Diabetes Mellitus
Mutation
Neurologic Gait Disorders
Spastic Paraparesis
Spondylosis
Stretch Reflex
Abnormal Reflexes
Corpus Callosum
Neural Conduction
Muscle Weakness
Peripheral Nervous System Diseases
Peripheral Nerves
Genes
Needles
Foot
Lower Extremity
Extremities
Muscles

All Science Journal Classification (ASJC) codes

  • Clinical Neurology

Cite this

A late-onset sporadic case of SPG4 (1726T>C mutant) accompanied by polyneuropathy with diabetes mellitus. / Fukunaga, Mami; Ohyagi, Yasumasa; Morita, Mitsuya; Shigeto, Hiroshi; Taniwaki, Takayuki; Kira, Jun-Ichi.

In: Clinical Neurology, Vol. 47, No. 6, 01.06.2007, p. 359-361.

Research output: Contribution to journalArticle

Fukunaga, Mami ; Ohyagi, Yasumasa ; Morita, Mitsuya ; Shigeto, Hiroshi ; Taniwaki, Takayuki ; Kira, Jun-Ichi. / A late-onset sporadic case of SPG4 (1726T>C mutant) accompanied by polyneuropathy with diabetes mellitus. In: Clinical Neurology. 2007 ; Vol. 47, No. 6. pp. 359-361.
@article{c88343a6f42b44e0852fc98189c0733f,
title = "A late-onset sporadic case of SPG4 (1726T>C mutant) accompanied by polyneuropathy with diabetes mellitus",
abstract = "We report a 73-year-old man with SPG4. From aged 53 he had diabetes mellitus and at 64 he developed spastic paraparesis and urinary disturbance. At 70 years, he began to walk with a stick and noted abnormal sensations in bilateral feet. There was no relevant family history. Moderate spasticity with mild muscle weakness, markedly brisk tendon reflex with pathological reflexes, and mildly abnormal sensation in bilateral lower extremities, and markedly spastic gait were found. MRI showed mild C4-C7 spondylosis and L4-5 disk protrusion but no abnormality of the corpus callosum. Nerve conduction and needle EMG studies revealed various abnormalities in distal (MCV, SCV) and proximal (F-wave) peripheral nerves, but no neurogenic changes in limb muscles. We found a missense spastin gene mutation (1726T>C) that causes Leu534Pro substitution. This spastin gene mutation was novel in Japanese, but has been reported in an Italian family. The present case's neuropathy might be related to diabetes mellitus, because SPG4 is generally not associated with neuropathy. However, recent studies suggest that SPG4 patients sometimes have subclinical neuropathy, and longer disease duration may contribute to peripheral neuropathy. Further study of clinical characteristics associated with the Leu534Pro mutation will be necessary.",
author = "Mami Fukunaga and Yasumasa Ohyagi and Mitsuya Morita and Hiroshi Shigeto and Takayuki Taniwaki and Jun-Ichi Kira",
year = "2007",
month = "6",
day = "1",
language = "English",
volume = "47",
pages = "359--361",
journal = "Clinical Neurology",
issn = "0009-918X",
publisher = "Societas Neurologica Japonica",
number = "6",

}

TY - JOUR

T1 - A late-onset sporadic case of SPG4 (1726T>C mutant) accompanied by polyneuropathy with diabetes mellitus

AU - Fukunaga, Mami

AU - Ohyagi, Yasumasa

AU - Morita, Mitsuya

AU - Shigeto, Hiroshi

AU - Taniwaki, Takayuki

AU - Kira, Jun-Ichi

PY - 2007/6/1

Y1 - 2007/6/1

N2 - We report a 73-year-old man with SPG4. From aged 53 he had diabetes mellitus and at 64 he developed spastic paraparesis and urinary disturbance. At 70 years, he began to walk with a stick and noted abnormal sensations in bilateral feet. There was no relevant family history. Moderate spasticity with mild muscle weakness, markedly brisk tendon reflex with pathological reflexes, and mildly abnormal sensation in bilateral lower extremities, and markedly spastic gait were found. MRI showed mild C4-C7 spondylosis and L4-5 disk protrusion but no abnormality of the corpus callosum. Nerve conduction and needle EMG studies revealed various abnormalities in distal (MCV, SCV) and proximal (F-wave) peripheral nerves, but no neurogenic changes in limb muscles. We found a missense spastin gene mutation (1726T>C) that causes Leu534Pro substitution. This spastin gene mutation was novel in Japanese, but has been reported in an Italian family. The present case's neuropathy might be related to diabetes mellitus, because SPG4 is generally not associated with neuropathy. However, recent studies suggest that SPG4 patients sometimes have subclinical neuropathy, and longer disease duration may contribute to peripheral neuropathy. Further study of clinical characteristics associated with the Leu534Pro mutation will be necessary.

AB - We report a 73-year-old man with SPG4. From aged 53 he had diabetes mellitus and at 64 he developed spastic paraparesis and urinary disturbance. At 70 years, he began to walk with a stick and noted abnormal sensations in bilateral feet. There was no relevant family history. Moderate spasticity with mild muscle weakness, markedly brisk tendon reflex with pathological reflexes, and mildly abnormal sensation in bilateral lower extremities, and markedly spastic gait were found. MRI showed mild C4-C7 spondylosis and L4-5 disk protrusion but no abnormality of the corpus callosum. Nerve conduction and needle EMG studies revealed various abnormalities in distal (MCV, SCV) and proximal (F-wave) peripheral nerves, but no neurogenic changes in limb muscles. We found a missense spastin gene mutation (1726T>C) that causes Leu534Pro substitution. This spastin gene mutation was novel in Japanese, but has been reported in an Italian family. The present case's neuropathy might be related to diabetes mellitus, because SPG4 is generally not associated with neuropathy. However, recent studies suggest that SPG4 patients sometimes have subclinical neuropathy, and longer disease duration may contribute to peripheral neuropathy. Further study of clinical characteristics associated with the Leu534Pro mutation will be necessary.

UR - http://www.scopus.com/inward/record.url?scp=34547098594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547098594&partnerID=8YFLogxK

M3 - Article

C2 - 17633111

AN - SCOPUS:34547098594

VL - 47

SP - 359

EP - 361

JO - Clinical Neurology

JF - Clinical Neurology

SN - 0009-918X

IS - 6

ER -